Bretylium tosylate in prevention of cardiac dysrhythmias after myocardial infarction
AUTOR(ES)
Taylor, S. H.
RESUMO
The prophylactic value of parenterally administered bretylium tosylate against the onset of dysrhythmias after acute myocardial infarction has been assessed by a controlled trial in 101 male patients. Bretylium significantly reduced the incidence of supraventricular dysrhythmias but was without significant effect on the incidence of ventricular dysrhythmias. The only serious side-effect of the drug was hypotension which occurred in one-third of the patients. It is concluded that prophylactic treatment of patients suffering from uncomplicated myocardial infarction with parenteral bretylium tosylate probably does not confer sufficient clinical benefit to warrant its recommendation for preventative use in this disease.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=487328Documentos Relacionados
- Bretylium tosylate in treatment of refractory ventricular arrhythmias complicating myocardial infarction.
- Relation between metabolic acidosis and cardiac dysrhythmias in acute myocardial infarction.
- Recent developments in secondary prevention and cardiac rehabilitation after acute myocardial infarction
- Recent developments in secondary prevention and cardiac rehabilitation after acute myocardial infarction
- Cardiac dysrhythmias after thoracotomy.
